Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes

Julia Fröbel, Ron Patrick Cadeddu, Sonja Hartwig, Ingmar Bruns, Christian M. Wilk, Andrea Kun̈dgen, Johannes C. Fischer, Thomas Schroeder, Ulrich G. Steidl, Ulrich Germing, Stefan Lehr, Rainer Haas, Akos Czibere

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Bleeding complications are a significant clinical problem in patients with myelodysplastic syndromes even at sufficient platelet counts (>50,000/μl). However, the underlying pathology of this hemorrhagic diathesis is still unknown. Here, we analyzed the platelet proteome of patients with myelodysplastic syndromes by quantitative two-dimensional difference gel electrophoresis followed by mass spectrometric protein identification. Proteins identified with lower concentrations, such as Talin-1, Vinculin, Myosin-9, Filmain-A, and Actin play critical roles in integrin αIIbβ 3 signaling and thus platelet aggregation. Despite normal agonist receptor expression, calcium flux, and granule release upon activation, the activation capacity of integrin αIIbβ3 was diminished in myelodysplastic syndrome platelets. Förster resonance energy transfer analysis showed a reduced co-localization of Talin-1 to the integrin's β3-subunit, which is required for receptor activation and fibrinogen binding. In addition, platelet spreading on immobilized fibrinogen was incomplete, and platelet aggregation assays confirmed a general defect in integrin-dependent platelet aggregation in patients with myelodysplastic syndromes. Our data provide novel aspects on the molecular pathology of impaired platelet function in myelodysplastic syndromes and suggest a mechanism of defective integrin αIIbβ3 signaling that may contribute to the hemorrhagic diathesis observed in these patients.

Original languageEnglish (US)
Pages (from-to)1272-1280
Number of pages9
JournalMolecular and Cellular Proteomics
Volume12
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Myelodysplastic Syndromes
Proteome
Platelets
Integrins
Blood Platelets
Agglomeration
Defects
Platelet Aggregation
Talin
Hemorrhagic Disorders
Fibrinogen Receptors
Two-Dimensional Difference Gel Electrophoresis
Chemical activation
Vinculin
Pathology
Molecular Pathology
Fibrinogen
Energy Transfer
Myosins
Platelet Count

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Analytical Chemistry

Cite this

Fröbel, J., Cadeddu, R. P., Hartwig, S., Bruns, I., Wilk, C. M., Kun̈dgen, A., ... Czibere, A. (2013). Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes. Molecular and Cellular Proteomics, 12(5), 1272-1280. https://doi.org/10.1074/mcp.M112.023168

Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes. / Fröbel, Julia; Cadeddu, Ron Patrick; Hartwig, Sonja; Bruns, Ingmar; Wilk, Christian M.; Kun̈dgen, Andrea; Fischer, Johannes C.; Schroeder, Thomas; Steidl, Ulrich G.; Germing, Ulrich; Lehr, Stefan; Haas, Rainer; Czibere, Akos.

In: Molecular and Cellular Proteomics, Vol. 12, No. 5, 05.2013, p. 1272-1280.

Research output: Contribution to journalArticle

Fröbel, J, Cadeddu, RP, Hartwig, S, Bruns, I, Wilk, CM, Kun̈dgen, A, Fischer, JC, Schroeder, T, Steidl, UG, Germing, U, Lehr, S, Haas, R & Czibere, A 2013, 'Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes', Molecular and Cellular Proteomics, vol. 12, no. 5, pp. 1272-1280. https://doi.org/10.1074/mcp.M112.023168
Fröbel, Julia ; Cadeddu, Ron Patrick ; Hartwig, Sonja ; Bruns, Ingmar ; Wilk, Christian M. ; Kun̈dgen, Andrea ; Fischer, Johannes C. ; Schroeder, Thomas ; Steidl, Ulrich G. ; Germing, Ulrich ; Lehr, Stefan ; Haas, Rainer ; Czibere, Akos. / Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes. In: Molecular and Cellular Proteomics. 2013 ; Vol. 12, No. 5. pp. 1272-1280.
@article{d159f49f5af14c819ab6886638b02e60,
title = "Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes",
abstract = "Bleeding complications are a significant clinical problem in patients with myelodysplastic syndromes even at sufficient platelet counts (>50,000/μl). However, the underlying pathology of this hemorrhagic diathesis is still unknown. Here, we analyzed the platelet proteome of patients with myelodysplastic syndromes by quantitative two-dimensional difference gel electrophoresis followed by mass spectrometric protein identification. Proteins identified with lower concentrations, such as Talin-1, Vinculin, Myosin-9, Filmain-A, and Actin play critical roles in integrin αIIbβ 3 signaling and thus platelet aggregation. Despite normal agonist receptor expression, calcium flux, and granule release upon activation, the activation capacity of integrin αIIbβ3 was diminished in myelodysplastic syndrome platelets. F{\"o}rster resonance energy transfer analysis showed a reduced co-localization of Talin-1 to the integrin's β3-subunit, which is required for receptor activation and fibrinogen binding. In addition, platelet spreading on immobilized fibrinogen was incomplete, and platelet aggregation assays confirmed a general defect in integrin-dependent platelet aggregation in patients with myelodysplastic syndromes. Our data provide novel aspects on the molecular pathology of impaired platelet function in myelodysplastic syndromes and suggest a mechanism of defective integrin αIIbβ3 signaling that may contribute to the hemorrhagic diathesis observed in these patients.",
author = "Julia Fr{\"o}bel and Cadeddu, {Ron Patrick} and Sonja Hartwig and Ingmar Bruns and Wilk, {Christian M.} and Andrea Kun̈dgen and Fischer, {Johannes C.} and Thomas Schroeder and Steidl, {Ulrich G.} and Ulrich Germing and Stefan Lehr and Rainer Haas and Akos Czibere",
year = "2013",
month = "5",
doi = "10.1074/mcp.M112.023168",
language = "English (US)",
volume = "12",
pages = "1272--1280",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "5",

}

TY - JOUR

T1 - Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes

AU - Fröbel, Julia

AU - Cadeddu, Ron Patrick

AU - Hartwig, Sonja

AU - Bruns, Ingmar

AU - Wilk, Christian M.

AU - Kun̈dgen, Andrea

AU - Fischer, Johannes C.

AU - Schroeder, Thomas

AU - Steidl, Ulrich G.

AU - Germing, Ulrich

AU - Lehr, Stefan

AU - Haas, Rainer

AU - Czibere, Akos

PY - 2013/5

Y1 - 2013/5

N2 - Bleeding complications are a significant clinical problem in patients with myelodysplastic syndromes even at sufficient platelet counts (>50,000/μl). However, the underlying pathology of this hemorrhagic diathesis is still unknown. Here, we analyzed the platelet proteome of patients with myelodysplastic syndromes by quantitative two-dimensional difference gel electrophoresis followed by mass spectrometric protein identification. Proteins identified with lower concentrations, such as Talin-1, Vinculin, Myosin-9, Filmain-A, and Actin play critical roles in integrin αIIbβ 3 signaling and thus platelet aggregation. Despite normal agonist receptor expression, calcium flux, and granule release upon activation, the activation capacity of integrin αIIbβ3 was diminished in myelodysplastic syndrome platelets. Förster resonance energy transfer analysis showed a reduced co-localization of Talin-1 to the integrin's β3-subunit, which is required for receptor activation and fibrinogen binding. In addition, platelet spreading on immobilized fibrinogen was incomplete, and platelet aggregation assays confirmed a general defect in integrin-dependent platelet aggregation in patients with myelodysplastic syndromes. Our data provide novel aspects on the molecular pathology of impaired platelet function in myelodysplastic syndromes and suggest a mechanism of defective integrin αIIbβ3 signaling that may contribute to the hemorrhagic diathesis observed in these patients.

AB - Bleeding complications are a significant clinical problem in patients with myelodysplastic syndromes even at sufficient platelet counts (>50,000/μl). However, the underlying pathology of this hemorrhagic diathesis is still unknown. Here, we analyzed the platelet proteome of patients with myelodysplastic syndromes by quantitative two-dimensional difference gel electrophoresis followed by mass spectrometric protein identification. Proteins identified with lower concentrations, such as Talin-1, Vinculin, Myosin-9, Filmain-A, and Actin play critical roles in integrin αIIbβ 3 signaling and thus platelet aggregation. Despite normal agonist receptor expression, calcium flux, and granule release upon activation, the activation capacity of integrin αIIbβ3 was diminished in myelodysplastic syndrome platelets. Förster resonance energy transfer analysis showed a reduced co-localization of Talin-1 to the integrin's β3-subunit, which is required for receptor activation and fibrinogen binding. In addition, platelet spreading on immobilized fibrinogen was incomplete, and platelet aggregation assays confirmed a general defect in integrin-dependent platelet aggregation in patients with myelodysplastic syndromes. Our data provide novel aspects on the molecular pathology of impaired platelet function in myelodysplastic syndromes and suggest a mechanism of defective integrin αIIbβ3 signaling that may contribute to the hemorrhagic diathesis observed in these patients.

UR - http://www.scopus.com/inward/record.url?scp=84877636843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877636843&partnerID=8YFLogxK

U2 - 10.1074/mcp.M112.023168

DO - 10.1074/mcp.M112.023168

M3 - Article

VL - 12

SP - 1272

EP - 1280

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 5

ER -